Health Catalyst, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $311.1M | $306.6M | $295.9M | $276.2M | $241.9M | $188.8M | $154.9M | $112.6M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $49.8M | $58.0M | $72.6M | $75.7M | $62.7M | $53.5M | $46.3M | $38.6M |
| SG&A Expense | $49.6M | $56.8M | $76.6M | $61.7M | $85.9M | $59.2M | $31.7M | $22.7M |
| Operating Income | $-160.9M | $-69.8M | $-126.9M | $-140.0M | $-143.7M | $-96.1M | $-54.9M | $-60.1M |
| Operating Margin | -51.7% | -22.8% | -42.9% | -50.7% | -59.4% | -50.9% | -35.4% | -53.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-177.3M | $-69.2M | $-117.8M | — | — | — | — | — |
| Income Tax Expense | $716.0K | $333.0K | $356.0K | $-4.3M | $-6.9M | $-1.2M | $142.0K | $-135.0K |
| Net Income | $-178.0M | $-69.5M | $-118.1M | $-137.4M | $-153.2M | $-115.0M | $-60.1M | $-62.0M |
| Net Margin | -57.2% | -22.7% | -39.9% | -49.7% | -63.3% | -60.9% | -38.8% | -55.1% |
| EPS (Basic) | $-2.55 | $-1.15 | $-2.09 | $-2.56 | $-3.23 | $-2.91 | $-6.43 | $-11.88 |
| EPS (Diluted) | $-2.55 | $-1.15 | $-2.09 | $-2.63 | $-3.23 | $-2.91 | $-6.43 | $-11.88 |
| Shares Outstanding (Basic) | 69.9M | 60.2M | 56.4M | 53.7M | 47.5M | 39.5M | 37.5M | — |
| Shares Outstanding (Diluted) | 69.9M | 60.2M | 56.4M | 54.1M | 47.5M | 39.5M | 37.5M | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |